SOFIA (Bulgaria), December 2 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its CEO Ognyan Donev has increased his interest in the company through several transactions on the regulated market of the Bulgarian Stock Exchange on December 1.